In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

Prostate cancer is the most common cancer found in men around the world. Each year, more than 1.4 million men are diagnosed with it. When the cancer is caught early and hasn’t spread ...

Prostate cancer is cancer of the prostate gland. Cancer is when abnormal cells start to divide and grow in an uncontrolled way. The cells can grow into surrounding tissues or organs, and may spread to ...

1Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. 2Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas. Search for other ...

One out of eight men develops prostate cancer. With the support from the Medical Research Future Fund (MRFF) Frontiers Initiative, the goal of the multidisciplinary multi-institutional ...

That none of these “scancers” (cancer caused by radiation exposure from a scan ... and 74 of them would not have been diagnosed through existing UK diagnostic screening pathways (prostate-specific ...

Look back at celebs' cancer journeys... The All My Children alum announced in January 2025 that he had been diagnosed with prostate cancer, his third cancer diagnosis throughout his life.

the radiotracer binds to prostate-specific membrane antigens (PSMA) expressed by the cancer cells. Following the same pathway, a therapy then targets the cancer cells, destroying them with ...

A urine test for prostate cancer has proved to be far more accurate at detection than the current blood tests used. The new technique is now the ‘prime candidate’ for potential clinical trials ...